BMC Health Services Research · 2021 · 12 citations · 36 references
Public AffairsInsuranceEpidemiologyHealth EconomicsHealth Services ResearchDirect Medical CostsDisease BurdenHealth Care CostsHealth Care Expenditure AnalysisHealth ExpenditureHealthcare Cost AnalysisDiagnostic CodingDisease-specific ExpenditureHealth Care Spending PatternsInsurance Claim AnalysisInsurance Claims DataOutpatient Care CostsOutpatient Care UseSpending Assignment
BACKGROUND: Decomposing health care spending by disease, type of care, age, and sex can lead to a better understanding of the drivers of health care spending. But the lack of diagnostic coding in outpatient care often precludes a decomposition by disease. Yet, health insurance claims data hold a variety of diagnostic clues that may be used to identify diseases. METHODS: In this study, we decompose total outpatient care spending in Switzerland by age, sex, service type, and 42 exhaustive and mutually exclusive diseases according to the Global Burden of Disease classification. Using data of a large health insurance provider, we identify diseases based on diagnostic clues. These clues include type of medication, inpatient treatment, physician specialization, and disease specific outpatient treatments and examinations. We determine disease-specific spending by direct (clues-based) and indirect (regression-based) spending assignment. RESULTS: Our results suggest a high precision of disease identification for many diseases. Overall, 81% of outpatient spending can be assigned to diseases, mostly based on indirect assignment using regression. Outpatient spending is highest for musculoskeletal disorders (19.2%), followed by mental and substance use disorders (12.0%), sense organ diseases (8.7%) and cardiovascular diseases (8.6%). Neoplasms account for 7.3% of outpatient spending. CONCLUSIONS: Our study shows the potential of health insurance claims data in identifying diseases when no diagnostic coding is available. These disease-specific spending estimates may inform Swiss health policies in cost containment and priority setting.
36
Gregory A. Roth, Degu Abate, Kalkidan Hassen Abate et al. · The Lancet · 2018 · 8.7K citations · Full text
Public Health, Health Sciences, Population Health Sciences +17
João Santos Silva, Silvana Tenreyro · The Review of Economics and Statistics · 2006 · 6.1K citations · Full text
US Health Care Spending by Payer and Health Condition, 1996-2016
Joseph L. Dieleman, Jackie Cao, Abby Chapin et al. · JAMA · 2020 · 1.3K citations · Full text
Public Affairs, Health Policy, Health Services Administration +17
Cost of disorders of the brain in Europe
P Andlin‐Sobocki, Bengt Jönsson, Hans‐Ulrich Wïttchen et al. · European Journal of Neurology · 2005 · 1.1K citations
US Spending on Personal Health Care and Public Health, 1996-2013
Joseph L. Dieleman, Ranju Baral, Maxwell Birger et al. · JAMA · 2016 · 1.1K citations · Full text